Can I increase atomoxetine (Strattera) from 40 mg to 80 mg directly, or should I use an intermediate dose?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 15, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Can You Go Directly from 40 mg to 80 mg of Strattera?

Yes, you can increase directly from 40 mg to 80 mg of atomoxetine (Strattera) after a minimum of 3 days at the 40 mg dose, as this is the FDA-approved dosing schedule for patients over 70 kg body weight and adults. 111

FDA-Approved Titration Schedule

The official FDA labeling provides clear guidance on dose escalation:

  • For patients over 70 kg and adults: Start at 40 mg total daily dose, then increase after a minimum of 3 days to the target dose of 80 mg 111
  • No intermediate dosing step is required or recommended between 40 mg and 80 mg
  • The 80 mg dose can be taken as a single morning dose or split into two divided doses (morning and late afternoon/evening) 1

Important Timing Considerations

Wait at least 3 days at 40 mg before increasing to 80 mg. This minimum waiting period allows for:

  • Initial tolerability assessment
  • Reduction of gastrointestinal side effects that are more common with rapid dose escalation 2

Why 80 mg is the Target Dose

The 80 mg dose is specifically designated as the target therapeutic dose for adults and adolescents over 70 kg 11. Research demonstrates that:

  • Effect sizes increase substantially when patients reach and maintain the 80 mg target dose 3
  • Real-world data show many patients are underdosed at approximately 60 mg/day, which may compromise treatment outcomes 4
  • Patients should remain at 80 mg for 4-6 weeks before judging efficacy, as atomoxetine's effect size continues to increase over time (reaching 0.82 effect size in the 80 mg group by 6 months) 3

Common Pitfall to Avoid

The most critical error is increasing the dose too rapidly, which significantly increases gastrointestinal side effects (particularly nausea) and initial somnolence 2. However, the FDA-approved 3-day minimum interval from 40 mg to 80 mg is designed to balance tolerability with achieving therapeutic dosing.

Further Dose Adjustments

If you don't achieve optimal response after 2-4 additional weeks at 80 mg, the dose may be increased to a maximum of 100 mg 11. However, there is no evidence supporting increased effectiveness at doses higher than the standard target 1.

Special Circumstances Requiring Different Dosing

You would need intermediate dosing or slower titration only if you:

  • Have hepatic impairment (reduce target to 50% for moderate or 25% for severe impairment) 11
  • Are taking strong CYP2D6 inhibitors (paroxetine, fluoxetine, quinidine) - in this case, stay at 40 mg for 4 weeks before increasing 11
  • Are a known CYP2D6 poor metabolizer - same slower titration applies 11

Related Questions

A patient on Strattera (atomoxetine) 60 mg reports persistent difficulty concentrating and focusing; what advice should be given?
Is starting atomoxetine 40 mg daily appropriate for an adult patient with attention‑deficit/hyperactivity disorder who weighs at least 70 kg and has no contraindications?
For an ADHD patient on atomoxetine (Strattera) 40 mg who experiences improvement that wanes toward the end of the day, what dosing adjustments are recommended?
What is the recommended initial dose of atomoxetine for adult ADHD?
Can I increase my Strattera (atomoxetine) dose to 50 mg now given I have been on 25 mg for less than a month and am experiencing agitation and withdrawal symptoms?
Can pre‑exposure prophylaxis (PrEP) be started before confirming HIV‑negative status and renal function (creatinine/eGFR) when lab results will take 2–3 days?
What are the characteristic physical examination findings in a patient with Graves disease?
For a patient with a documented positive purified protein derivative (PPD) test 20 years ago, no active tuberculosis disease, and a normal chest X‑ray, is surveillance without immediate anti‑tuberculosis treatment appropriate?
How do I calculate transferrin saturation for a patient with restless‑leg syndrome who has a serum iron of 55 µg/dL and a total iron‑binding capacity of 300 µg/dL?
Is desvenlafaxine safe and appropriate for off‑label use in a 16‑year‑old adolescent?
Is Zoloft (sertraline) appropriate for pain management, and what dose and duration are recommended?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.